Radiation Oncology Basics — MCQs

Radiation Oncology Basics Indian Medical PG Practice Questions and MCQs

Question 11: Radiation caries is an example of:

A. Early childhood caries.
B. Rampant caries. (Correct Answer)
C. Exposure caries.
D. None of the above.

Explanation: **Explanation:** **Radiation caries** is a highly destructive form of dental decay that occurs in patients receiving radiotherapy for head and neck cancers. It is classified as a type of **Rampant Caries** because of its rapid onset, widespread involvement of multiple teeth, and progression to surfaces usually resistant to decay (such as incisal edges and cervical margins). The underlying mechanism is primarily indirect: radiation causes fibrosis and atrophy of the salivary glands (especially the parotid), leading to severe **xerostomia** (dry mouth). The loss of the buffering capacity, minerals, and antimicrobial properties of saliva results in a shift toward acidogenic flora, leading to the rapid "rampant" destruction of tooth structure. **Analysis of Options:** * **Option B (Correct):** Rampant caries refers to a sudden, widespread outbreak of dental caries affecting many teeth. Radiation caries fits this definition perfectly due to its aggressive nature post-irradiation. * **Option A (Incorrect):** Early childhood caries (nursing bottle syndrome) is specific to infants and toddlers, usually due to prolonged exposure to sugary liquids in bottles. * **Option C (Incorrect):** Exposure caries is not a standard clinical classification; while radiation "exposes" the teeth to risk, the clinical manifestation is categorized under rampant caries. **High-Yield Clinical Pearls for NEET-PG:** * **Critical Dose:** Salivary gland dysfunction can occur at doses as low as **20-30 Gy**. * **Clinical Presentation:** Typically starts at the **cervical (neck) region** of the teeth. * **Management:** Pre-radiation dental clearance, lifelong topical fluoride application, and meticulous oral hygiene. * **Osteoradionecrosis (ORN):** A more severe complication of radiation involving bone (usually the mandible), often triggered by post-radiation tooth extractions.

Question 12: What is the most common method of radiotherapy?

A. Teletherapy (Correct Answer)
B. Brachytherapy
C. Systemic Radiotherapy
D. Interstitial Radiotherapy

Explanation: **Explanation:** The correct answer is **Teletherapy (Option A)**. In clinical oncology, radiotherapy is broadly classified based on the distance between the radiation source and the patient. 1. **Why Teletherapy is correct:** Teletherapy (External Beam Radiation Therapy - EBRT) is the most widely used method. In this technique, the radiation source (such as a Linear Accelerator or Cobalt-60 machine) is located at a distance from the patient (usually 80–100 cm). It is the standard of care for the majority of solid tumors (e.g., Lung, Breast, Head, and Neck) because it can treat large volumes and deep-seated tumors non-invasively. 2. **Why other options are incorrect:** * **Brachytherapy (Option B):** This involves placing the radiation source inside or in immediate proximity to the tumor. While highly effective for localized dose escalation, its use is limited to specific sites like the cervix, prostate, and esophagus. * **Systemic Radiotherapy (Option C):** This involves administering radioactive isotopes (e.g., Iodine-131 for thyroid cancer) orally or intravenously. It is specialized for specific systemic malignancies and is not the "most common" modality. * **Interstitial Radiotherapy (Option D):** This is a specific *subtype* of Brachytherapy where sources are placed directly into the tissue (e.g., tongue or breast). It is a localized technique, not a primary general method. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** The **Linear Accelerator (LINAC)** is the most common machine used for teletherapy today, replacing the older Cobalt-60 units. * **Unit of Measurement:** Radiation dose is measured in **Gray (Gy)**; 1 Gy = 1 Joule/kg. * **Fractionation:** Teletherapy is typically delivered in small daily doses (fractions) to allow normal tissue repair while maximizing tumor kill. * **Inverse Square Law:** This principle governs the dose distribution in teletherapy, where intensity decreases inversely with the square of the distance from the source.

Question 13: What is the conventional daily dose regimen in external beam radiotherapy?

A. 100-150 cGy
B. 150-170 cGy
C. 180-200 cGy (Correct Answer)
D. 225-250 cGy

Explanation: ### Explanation **1. Understanding the Correct Answer (C: 180-200 cGy)** In conventional external beam radiotherapy (EBRT), the total dose required to kill a tumor is divided into small daily increments called **fractions**. The standard or "conventional" fractionation schedule is **180 to 200 cGy (1.8–2.0 Gy) per day**, administered five days a week for 5 to 7 weeks. The underlying radiobiological principle is the **"4 Rs" of Radiobiology**: Repair, Re-oxygenation, Redistribution, and Repopulation. This specific dose range (1.8–2.0 Gy) is the "sweet spot" that maximizes damage to tumor cells while allowing normal surrounding tissues to **repair** sublethal DNA damage between treatments, thereby minimizing late-term complications. **2. Why Other Options are Incorrect** * **Options A & B (100-170 cGy):** These doses are considered **Hyperfractionation**. While smaller doses per fraction are gentler on normal tissues, they require treating the patient multiple times a day to reach the therapeutic threshold, which is not the "conventional" standard. * **Option D (225-250 cGy):** Doses above 200 cGy per fraction are termed **Hypofractionation**. While used in specific scenarios (like palliative care or stereotactic treatments), higher daily doses increase the risk of late-tissue toxicity (fibrosis, necrosis) in standard curative settings. **3. High-Yield Clinical Pearls for NEET-PG** * **Standard Unit:** 1 Gray (Gy) = 100 centiGray (cGy) = 1 Joule/kg. * **Hyperfractionation:** Smaller dose per fraction (<1.8 Gy), increased number of fractions, same total time. Aim: Decrease late effects. * **Hypofractionation:** Larger dose per fraction (>2.2 Gy), fewer fractions. Aim: Convenience or for slow-growing tumors (e.g., Prostate). * **Accelerated Fractionation:** Same dose per fraction, but total treatment time is reduced (e.g., treating 6 days a week). Aim: Overcome tumor repopulation.

Question 14: Total body irradiation is routinely done before which of the following transplantations?

A. Lungs
B. Liver
C. Bone marrow (Correct Answer)
D. Pancreas

Explanation: **Explanation:** **Total Body Irradiation (TBI)** is a form of radiotherapy where the entire body is exposed to ionizing radiation. Its primary clinical application is as part of the **conditioning regimen** prior to **Bone Marrow Transplantation (BMT)** or Hematopoietic Stem Cell Transplantation (HSCT). **Why Bone Marrow is the correct answer:** TBI serves three critical functions in BMT: 1. **Immunosuppression:** It destroys the recipient's immune system to prevent the rejection of the donor's stem cells (host-versus-graft reaction). 2. **Myeloablation:** It creates "physical space" in the bone marrow by destroying the recipient's existing diseased or healthy marrow, allowing the new stem cells to engraft. 3. **Eradication:** In cases of leukemia or lymphoma, it helps kill residual cancer cells in "sanctuary sites" (like the CNS or testes) where chemotherapy may not penetrate effectively. **Why other options are incorrect:** * **Lungs, Liver, and Pancreas:** These are solid organ transplants. The primary challenge in solid organ transplantation is preventing organ rejection through pharmacological immunosuppression (e.g., Cyclosporine, Tacrolimus). TBI is not used because it would cause catastrophic systemic toxicity and organ failure without providing the necessary localized benefit for solid graft survival. **High-Yield Clinical Pearls for NEET-PG:** * **Dose:** TBI is usually delivered in **fractionated doses** (e.g., 12 Gy in 6 fractions over 3 days) to reduce toxicity to the lungs, which is the dose-limiting organ. * **Common Side Effects:** Early effects include nausea, vomiting, and parotitis. Late effects include **cataracts** (most common late complication), pneumonitis, and secondary malignancies. * **Dose Rate:** Low dose rates are preferred to allow for better repair of sub-lethal damage in normal tissues (especially the lungs).

Question 15: Which of the following is NOT a radiosensitizing agent?

A. Metronidazole
B. Actinomycin-D
C. Hyperbaric Oxygen
D. Chlorhexidine (Correct Answer)

Explanation: **Explanation:** Radiosensitizers are chemical or pharmacological agents that enhance the lethal effects of ionizing radiation on tumor cells. The correct answer is **Chlorhexidine**, which is a topical antiseptic used for skin disinfection and oral rinses; it has no pharmacological role in modulating radiation sensitivity. **Why the other options are Radiosensitizers:** * **Hyperbaric Oxygen (C):** Oxygen is the most potent natural radiosensitizer. It "fixes" radiation-induced free radical damage to DNA, making it permanent (the Oxygen Fixation Hypothesis). Hypoxic tumors are resistant to radiation, so increasing oxygen tension enhances cell kill. * **Metronidazole (A):** This is a "hypoxic cell sensitizer." It acts as an oxygen mimic, diffusing into poorly vascularized tumor areas to stabilize DNA damage in the absence of actual oxygen. * **Actinomycin-D (B):** Many cytotoxic chemotherapy drugs act as radiosensitizers by inhibiting DNA repair or synchronizing cells into the radiosensitive phases of the cell cycle (G2/M). Other examples include Cisplatin, 5-Fluorouracil, and Hydroxyurea. **High-Yield NEET-PG Pearls:** 1. **Oxygen Enhancement Ratio (OER):** The ratio of radiation dose required to cause a specific biological effect in the absence of oxygen to the dose required in the presence of oxygen. For X-rays, OER is typically **2.5 to 3.0**. 2. **Radioprotectors:** Conversely, agents like **Amifostine** (a free radical scavenger) are used to protect normal tissues (like salivary glands) from radiation damage. 3. **The 4 R’s of Radiobiology:** Repair, Reassortment, Repopulation, and Reoxygenation.

Question 16: What is the recommended quantum of radiation at point B in carcinoma of the cervix?

A. 1000 cGy
B. 2000 cGy
C. 5000 cGy (Correct Answer)
D. 8000 cGy

Explanation: ### Explanation In the Manchester System for Brachytherapy in cervical cancer, **Point B** is defined as a point **2 cm superior** to the external cervical os and **5 cm lateral** to the midline. **Why 5000 cGy is correct:** Point B represents the **pelvic side wall**, specifically the location of the obturator lymph nodes. The goal of radiation at Point B is to treat potential regional lymphatic spread. While Point A (the paracervical triangle) receives a high curative dose of approximately 7500–8000 cGy, the dose at Point B is typically **one-third to two-thirds** of the Point A dose. In standard clinical practice, the cumulative dose (External Beam Radiation + Brachytherapy) to Point B is approximately **5000–5500 cGy**. **Why incorrect options are wrong:** * **1000 cGy & 2000 cGy:** These doses are sub-therapeutic for cervical malignancy and would fail to control microscopic nodal disease. * **8000 cGy:** This is the typical total dose delivered to **Point A**. Delivering 8000 cGy to Point B would exceed the tolerance of surrounding normal tissues (rectum and bladder) and is physically impossible with standard brachytherapy pear-shaped distributions without causing severe necrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Point A:** 2 cm superior to the external os and 2 cm lateral to the uterine canal. It represents the crossing of the **uterine artery and the ureter**. * **Point B:** 5 cm lateral to the midline (3 cm lateral to Point A). It represents the **obturator nodes**. * **Tolerance Doses (TD 5/5):** Bladder (65 Gy), Rectum (60 Gy). * **ICRU 38:** Modern reporting has shifted from Point A/B to volume-based assessments (GEC-ESTRO guidelines), but Point A/B remains a frequent examiner favorite.

Question 17: Which of the following malignancies responds best to radiotherapy?

A. Renal Cell Carcinoma
B. Adenocarcinoma Colon
C. Malignant Melanoma
D. Cervical Carcinoma (Correct Answer)

Explanation: **Explanation:** The radiosensitivity of a tumor depends on its histological origin, degree of differentiation, and oxygenation. In clinical oncology, tumors are classified as radiosensitive, radioresponsive, or radioresistant. **1. Why Cervical Carcinoma is Correct:** Cervical carcinoma (most commonly Squamous Cell Carcinoma) is highly **radioresponsive**. Radiotherapy (both External Beam Radiation and Brachytherapy) is a primary treatment modality for locally advanced stages. Squamous cells generally have a high turnover rate and a predictable response to ionizing radiation, which induces DNA damage and subsequent apoptosis in these rapidly dividing cells. **2. Why the Other Options are Incorrect:** * **Renal Cell Carcinoma (RCC):** Classically considered **radioresistant**. While SBRT is sometimes used for palliation, RCC does not respond well to standard fractionation. Surgery remains the mainstay of treatment. * **Adenocarcinoma of the Colon:** Generally shows **poor radiosensitivity**. Surgery and chemotherapy are the primary treatments; radiation is rarely used for colon cancer (unlike rectal cancer, where it is used pre-operatively). * **Malignant Melanoma:** Notoriously **radioresistant** due to efficient DNA repair mechanisms and high levels of melanin, which may provide some radioprotection. It requires very high doses per fraction (hypofractionation) to see a response. **Clinical Pearls for NEET-PG:** * **Most Radiosensitive Tumor:** Seminoma (followed by Lymphoma and Wilms tumor). * **Most Radiosensitive Cell in the Body:** Lymphocyte (exception to the Law of Bergonie and Tribondeau). * **Most Radiosensitive Phase of Cell Cycle:** **M phase** (followed by G2). * **Most Radioresistant Phase:** **S phase** (specifically late S phase). * **Law of Bergonie and Tribondeau:** Radiosensitivity is directly proportional to the reproductive rate and inversely proportional to the degree of differentiation.

Question 18: All are true about stereotactic radiosurgery except?

A. X-rays are used
B. A form of radiotherapy
C. Used in AV malformation
D. Damage to nearby structures is significant (Correct Answer)

Explanation: **Explanation:** Stereotactic Radiosurgery (SRS) is a highly precise form of radiation therapy designed to deliver a single, high dose of ionizing radiation to a specific target while minimizing exposure to surrounding healthy tissues. **Why Option D is the Correct Answer (The "Except" statement):** The hallmark of SRS is its **steep dose gradient**. Because it uses multiple convergent beams and rigid immobilization (stereotactic frames or image guidance), the radiation dose drops off rapidly outside the target volume. This ensures that **damage to nearby structures is minimal**, not significant. This precision allows for the treatment of lesions located near critical structures like the brainstem or optic nerves. **Analysis of Incorrect Options:** * **Option A (X-rays are used):** This is true. Linear accelerators (LINAC) use high-energy X-rays (photons) to perform SRS. (Note: Gamma Knives use Gamma rays, and CyberKnives use X-rays). * **Option B (A form of radiotherapy):** This is true. Despite the name "surgery," no incision is made; it is a specialized non-invasive radiation technique. * **Option C (Used in AV malformation):** This is true. SRS is a gold-standard treatment for small-to-medium Arteriovenous Malformations (AVMs), especially those in surgically inaccessible areas. **High-Yield Clinical Pearls for NEET-PG:** * **Definition:** SRS is typically delivered in a **single fraction** (or up to 5 fractions, termed Stereotactic Radiotherapy). * **Common Indications:** Vestibular Schwannomas (Acoustic Neuroma), Meningiomas, Brain Metastases, Trigeminal Neuralgia, and AVMs. * **Key Modalities:** Gamma Knife (Cobalt-60 source), LINAC-based (X-rays), and CyberKnife (robotic arm). * **Radiobiology:** Unlike conventional radiotherapy which relies on the "4 Rs," SRS works primarily through direct vascular damage and cellular necrosis.

Question 19: Which of the following tumors is least sensitive to radiotherapy?

A. Ewing's sarcoma
B. Osteosarcoma (Correct Answer)
C. Wilms' tumor
D. Neuroblastoma

Explanation: In radiation oncology, tumors are classified based on their **radiosensitivity**, which refers to the relative susceptibility of cells and tissues to the ionizing effects of radiation. ### **Why Osteosarcoma is the Correct Answer** **Osteosarcoma** is a primary bone malignancy characterized by the production of osteoid (bone matrix) by malignant cells. It is classically considered a **radioresistant** tumor. Because its cells have robust DNA repair mechanisms and the dense osteoid matrix may contribute to a hypoxic microenvironment (making it less susceptible to free radical damage), radiotherapy is rarely used as a primary treatment. The mainstay of management is surgical resection combined with chemotherapy. ### **Explanation of Incorrect Options** * **Ewing’s Sarcoma:** Unlike osteosarcoma, this is a highly **radiosensitive** small round blue cell tumor. Radiotherapy is a standard component of management, especially when surgical margins are close or the tumor is unresectable. * **Wilms’ Tumor (Nephroblastoma):** This pediatric renal tumor is very sensitive to radiation. Radiotherapy is frequently used in advanced stages (Stage III and IV) to treat the flank or whole abdomen. * **Neuroblastoma:** Another small round blue cell tumor of childhood that is highly radiosensitive. Radiation is often used for local control in high-risk cases. ### **NEET-PG High-Yield Pearls** * **Most Radiosensitive Tumor:** Seminoma (Dysgerminoma in females). * **Radiosensitive "Small Round Blue Cell" Group:** Includes Ewing’s, Neuroblastoma, Wilms’ tumor, and Lymphoma. * **Highly Radioresistant Tumors:** Osteosarcoma, Malignant Melanoma, Renal Cell Carcinoma (RCC), and Pancreatic Adenocarcinoma. * **Bergonie-Tribondeau Law:** Cells are more radiosensitive if they have a high mitotic rate, a long mitotic future, and are undifferentiated.

Question 20: Which of the following tumors is not radiosensitive?

A. Lymphoma
B. Seminoma
C. Melanoma (Correct Answer)
D. Multiple myeloma

Explanation: **Explanation:** Radiosensitivity refers to the relative susceptibility of cells, tissues, or tumors to the ionizing effects of radiation. In clinical oncology, tumors are categorized based on their response to standard doses of radiotherapy. **Why Melanoma is the Correct Answer:** **Melanoma** is classically considered a **radioresistant** tumor. At a cellular level, melanoma cells possess highly efficient DNA repair mechanisms and high levels of endogenous antioxidants (like melanin precursors), which mitigate the oxidative stress caused by radiation. While radiotherapy may be used for palliation or specific brain metastases, it is not a primary curative modality because the tumor does not reliably regress with standard doses. **Analysis of Incorrect Options:** * **Lymphoma (Option A):** These are **highly radiosensitive**. Lymphocytes are among the most sensitive cells in the body (Bergonie-Tribondeau law), and even low doses of radiation can induce rapid apoptosis in lymphomatous tissue. * **Seminoma (Option B):** This is the classic example of a **highly radiosensitive** solid tumor. Radiotherapy was historically the standard of care for early-stage seminoma due to its predictable and dramatic response. * **Multiple Myeloma (Option D):** Plasma cell dyscrasias are **radiosensitive**. Localized radiation is highly effective for treating plasmacytomas or providing pain relief for lytic bone lesions. **High-Yield Clinical Pearls for NEET-PG:** * **Most Radiosensitive Tumor:** Dysgerminoma (females) and Seminoma (males). * **Most Radiosensitive Phase of Cell Cycle:** **G2 and M phases** (M is the most sensitive). * **Most Radioresistant Phase:** **S phase** (specifically late S phase). * **Bergonie-Tribondeau Law:** Cells that are rapidly dividing, have a long mitotic future, and are undifferentiated are the most radiosensitive. * **Other Radioresistant Tumors:** Osteosarcoma, Glioblastoma Multiforme (GBM), and Pancreatic Adenocarcinoma.

Practice by Chapter

Principles of Radiation Therapy

Practice Questions

Radiation Therapy Equipment

Practice Questions

Treatment Planning Process

Practice Questions

External Beam Radiation Therapy

Practice Questions

Brachytherapy

Practice Questions

3D Conformal Radiation Therapy

Practice Questions

Intensity-Modulated Radiation Therapy

Practice Questions

Image-Guided Radiation Therapy

Practice Questions

Stereotactic Radiosurgery

Practice Questions

Total Body Irradiation

Practice Questions

Palliative Radiation Therapy

Practice Questions

Combined Modality Treatments

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free